After Doc Uproar, NCCN Reverses Prostate Cancer Guidance
The cancer organization today largely reinstated its former advice that men with low-risk prostate cancer be offered active surveillance as the lone ‘preferred’ initial treatment option.
Related Articles
Epicutaneous Immunotherapy: The Future of Peanut Allergy Treatment?
Longer term use of a skin patch helps treat peanut allergies in some children, a new study finds.
AML: Monitor Early Measurable Residual Disease to Optimize Outcomes
Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.
A Woman With Atraumatic Wrist Pain
The patient’s past medical history is notable only for hypothyroidism.
Polypharmacy in Psychiatry: Good, Bad, or Just Unavoidable?
Studies suggest psychotropic polypharmacy may be on the rise. But experts say whether that’s good or bad — or even unavoidable — is more nuanced.
Dermatomyositis Misdiagnosis Common, Affects Outcomes
A retrospective study highlights the high misdiagnosis rates of dermatomyositis, particularly its amyopathic subtype, and the associated increase in hospitalizations and worse lung function.
Hallucinogens May Elevate Death Risk by More Than Twofold
Future research will show whether the change in the availability of hallucinogens affects the risks associated with these drugs.
An 18-Year-Old Woman Who Fainted While Backpacking
An 18-year-old woman had a syncopal episode while backpacking. She does not recall any antecedent chest pain, shortness of breath, palpitations, or dizziness. What’s the…
Stress: A New Cancer Risk Factor?
Even everyday stress, the kind that many people experience, impairs the cancer-fighting immune system.
Is Intermittent Fasting Worth Considering for Your Patients?
Studies suggest types of fasting can lead to moderate weight loss and other health benefits in overweight and obese people, but only some doctors use…